Possibility of autologous tumor-derived heat shock protein as a tumor vaccine for cancer immunotherapy

T. Ishii, A. Hizuta, T. Yamano, Heiichiro Udono, E. Nakayama, N. Tanaka

Research output: Contribution to journalArticle

Abstract

Adjuvant-free vaccination with tumor-derived heat shock protein (HSP)- peptide complex has been previously shown to elicit tumor-specific protective and therapeutic immunity in murine systems. We investigated the in vitro effect of hsp70 preparations purified from surgically resected human colon cancer on autologous and allogeneic peripheral blood mononuclear cells (PBMC). The secretion of a considerable amount of TNF-α and INF-γ was observed both in autologous and allogeneic PBMC, while the proliferative response and tumor-specific cytotoxic activity were induced only in autologous PBMC. These results suggest that autologous tumor-derived HSP may not only serve as a nonspecific adjuvant but also act as a specific tumor vaccine for cancer immunotherapy.

Original languageEnglish
Pages (from-to)41-43
Number of pages3
JournalBiotherapy
Volume13
Issue number1
Publication statusPublished - 1999

Fingerprint

Cancer Vaccines
Heat-Shock Proteins
Immunotherapy
Blood Cells
Neoplasms
Colonic Neoplasms
Immunity
Vaccination
Peptides

Keywords

  • Adjuvant
  • Heat shock protein
  • Tumor vaccine

ASJC Scopus subject areas

  • Cancer Research
  • Immunology and Allergy

Cite this

Ishii, T., Hizuta, A., Yamano, T., Udono, H., Nakayama, E., & Tanaka, N. (1999). Possibility of autologous tumor-derived heat shock protein as a tumor vaccine for cancer immunotherapy. Biotherapy, 13(1), 41-43.

Possibility of autologous tumor-derived heat shock protein as a tumor vaccine for cancer immunotherapy. / Ishii, T.; Hizuta, A.; Yamano, T.; Udono, Heiichiro; Nakayama, E.; Tanaka, N.

In: Biotherapy, Vol. 13, No. 1, 1999, p. 41-43.

Research output: Contribution to journalArticle

Ishii, T, Hizuta, A, Yamano, T, Udono, H, Nakayama, E & Tanaka, N 1999, 'Possibility of autologous tumor-derived heat shock protein as a tumor vaccine for cancer immunotherapy', Biotherapy, vol. 13, no. 1, pp. 41-43.
Ishii, T. ; Hizuta, A. ; Yamano, T. ; Udono, Heiichiro ; Nakayama, E. ; Tanaka, N. / Possibility of autologous tumor-derived heat shock protein as a tumor vaccine for cancer immunotherapy. In: Biotherapy. 1999 ; Vol. 13, No. 1. pp. 41-43.
@article{3a1e549f7065465c846ead7ea18d9918,
title = "Possibility of autologous tumor-derived heat shock protein as a tumor vaccine for cancer immunotherapy",
abstract = "Adjuvant-free vaccination with tumor-derived heat shock protein (HSP)- peptide complex has been previously shown to elicit tumor-specific protective and therapeutic immunity in murine systems. We investigated the in vitro effect of hsp70 preparations purified from surgically resected human colon cancer on autologous and allogeneic peripheral blood mononuclear cells (PBMC). The secretion of a considerable amount of TNF-α and INF-γ was observed both in autologous and allogeneic PBMC, while the proliferative response and tumor-specific cytotoxic activity were induced only in autologous PBMC. These results suggest that autologous tumor-derived HSP may not only serve as a nonspecific adjuvant but also act as a specific tumor vaccine for cancer immunotherapy.",
keywords = "Adjuvant, Heat shock protein, Tumor vaccine",
author = "T. Ishii and A. Hizuta and T. Yamano and Heiichiro Udono and E. Nakayama and N. Tanaka",
year = "1999",
language = "English",
volume = "13",
pages = "41--43",
journal = "Biotherapy",
issn = "0914-2223",
publisher = "Japanese Society for Cancer Chemotherapy",
number = "1",

}

TY - JOUR

T1 - Possibility of autologous tumor-derived heat shock protein as a tumor vaccine for cancer immunotherapy

AU - Ishii, T.

AU - Hizuta, A.

AU - Yamano, T.

AU - Udono, Heiichiro

AU - Nakayama, E.

AU - Tanaka, N.

PY - 1999

Y1 - 1999

N2 - Adjuvant-free vaccination with tumor-derived heat shock protein (HSP)- peptide complex has been previously shown to elicit tumor-specific protective and therapeutic immunity in murine systems. We investigated the in vitro effect of hsp70 preparations purified from surgically resected human colon cancer on autologous and allogeneic peripheral blood mononuclear cells (PBMC). The secretion of a considerable amount of TNF-α and INF-γ was observed both in autologous and allogeneic PBMC, while the proliferative response and tumor-specific cytotoxic activity were induced only in autologous PBMC. These results suggest that autologous tumor-derived HSP may not only serve as a nonspecific adjuvant but also act as a specific tumor vaccine for cancer immunotherapy.

AB - Adjuvant-free vaccination with tumor-derived heat shock protein (HSP)- peptide complex has been previously shown to elicit tumor-specific protective and therapeutic immunity in murine systems. We investigated the in vitro effect of hsp70 preparations purified from surgically resected human colon cancer on autologous and allogeneic peripheral blood mononuclear cells (PBMC). The secretion of a considerable amount of TNF-α and INF-γ was observed both in autologous and allogeneic PBMC, while the proliferative response and tumor-specific cytotoxic activity were induced only in autologous PBMC. These results suggest that autologous tumor-derived HSP may not only serve as a nonspecific adjuvant but also act as a specific tumor vaccine for cancer immunotherapy.

KW - Adjuvant

KW - Heat shock protein

KW - Tumor vaccine

UR - http://www.scopus.com/inward/record.url?scp=0033062532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033062532&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033062532

VL - 13

SP - 41

EP - 43

JO - Biotherapy

JF - Biotherapy

SN - 0914-2223

IS - 1

ER -